SLC2A1 and Miyoshi myopathy: Thus, in these two unrelated datasets from patients affected by early-onset MM, we observe a very similar down-regulation of most glycolytic pathway enzymes as observed in our mfn1,2 model, with the same orthologous proteins (e.g., SLC2A1, HK2, and LDHB) as exceptions to this trend.